Abstract: A previously described self-complementary oligodeoxynucleotide termed triplex-forming oligodeoxynucleotide (TFO A), 54 bases in length, designed against the polypurine tract of HIV-1 RNA, inhibited viral replication at a 1 to 3 microM concentration in acutely infected cells, whereas antisense and scrambled sequence oligodeoxynucleotides were ineffective. Three HIV-1 viral isolates from patients of clinical categories A1, B, and C3 were transmitted to peripheral blood mononuclear cells and tested for production of p24 antigen and syncytium formation in the absence and in the presence of either TFO A or a control oligodeoxynucleotide of randomized sequence. No p24 antigen or syncytia were detected for up to 30 days when TFO A was added to the cells. Viability of the cells was found not to be affected by the drugs compared to controls within 2 weeks. Analysis of viral DNA synthesis by PCR for the LTR and gag gene indicated no DNA signal, suggesting that TFO A affects viral replication before formation of a DNA provirus. Measurements of the stability of TFO A indicate a half-life of about 2 hr. A two-dimensional computer fold analysis of TFO A suggested a self-complementary hairpin-loop configuration with GC-rich stems and single-stranded 5' and 3' ends. Since intracellular triplex formation may not be an efficient process, the observed inhibitory effect may be due to a direct inhibition of the RT and RNase H enzyme activities by the oligodeoxynucleotide. However, a triple-helix effect on the incoming RNA may play a role as well. 
INTRODUCTION
pairing with the preformed RNA-DNA hybrid, is capable of triple-helix formation. The four nucleotides at either terminus We have described a culture system based on the acute and the (T)4 linker were modified by phosphorothioates. This infection of an HTLV-I-transformed T cell line with the molecule is capable of exerting antiviral activity based on triplehuman immunodeficiency virus type 1 (HIV-1) to evaluate the helix interaction. This is because the heteroduplex forms around long-term efficacy of antiretroviral treatment based on a triple a purine-rich target.3 helix-forming oligodeoxynucleotide.1 It has been shown that a
The polypurine tract serves an important function in retrosynthetic, 54-base long oligodeoxynucleotide (ODN) , termed viral replication since it provides the primer for the secondtriplex-forming oligodeoxynucleotide A (TFO A), could inhibit strand DNA synthesis. After a full-length minus-strand DNA HIV-1 replication in an acute infection, when virus was added copy has been synthesized the RNase H activity of the reverse to an uninfected susceptible cell line C81-66/45. This transcriptase (RT) were, respectively, HIV-G3-BIO (5' AGTGGATAATC-CTGGGATTAAATA 3') and HIV-G7-DIG (5' AATAGTAA-GAATGTATAGCCCT 3'), and HIV-L2-BIO (5' GGTCT-GAGGGATCTCTAGTTACCAG 3') and HIV-L7-DIG (5' GCACTCAAGGCAAGCTTTATTGAGGC 3'). This PCR analysis has the ability to detect a single copy of HIV-1 DNA.
Analysis of triplex-forming oligodeoxynucleotide stability TFO A and TFO SC were 5' end-labeled using [7 Fig. 3A and B) . Such Analysis of the stability of triplex-forming oligodeoxynucleotides
To evaluate the contribution of the stability of TFOs to the efficacy of these compounds, TFO A and TFO SC were radioactively labeled and added to cell cultures (Fig. 4) 
